Novozymes is the world leader in bioinnovation. Our business is industrial enzymes, microorganisms, and biopharmaceutical ingredients. We help companies make more from less as our solutions save energy and raw materials, and reduce waste. The result is higher quality, lower costs, and a better environment. Our biological solutions are used in the production of numerous products such as biofuels, detergents, food, and animal feed.
In 2009, we achieved revenue of DKK 8,448 million based on a large portfolio of products and services worldwide. Our business consists of two segments: Enzyme Business and BioBusiness. Around 14% of our revenue is spent on research and development, and we currently hold more than 6,000 patents, which indicates the possibilities when nature and technology join forces. We number over 5,200 employees globally.
We use biotechnology to challenge convention and find sustainable solutions. We ask the world to “Rethink Tomorrow.” Our solutions are based on a unique technology platform that provides a wealth of opportunity for the world’s industries. Gene technology, microbial techniques, and fermentation technology are some of the biotechnological tools on which we base our business. Combining industrial insight with this technology platform, we partner with customers across a broad range of industries to create tomorrow’s industrial biosolutions that not only improve the use of our planet’s resources but also our customers’ business.
Sustainability is an integral part of our business, and we enable our customers to optimize their use of raw materials and energy, thereby reducing the environmental impact of their operations. In 2009 alone, the worldwide application of our bioinnovation enabled reductions in CO2 emissions of approximately 27 million tons.
We believe that decency and responsibility in business are about being aware of and acting upon important stakeholder relations, as well as being committed to international agreements and universal values: